CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 94 filers reported holding CUE BIOPHARMA INC in Q3 2020. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $714,000 | -10.4% | 58,500 | -8.2% | 0.00% | 0.0% |
Q4 2020 | $797,000 | -20.9% | 63,739 | -4.9% | 0.00% | 0.0% |
Q3 2020 | $1,008,000 | -35.1% | 66,988 | +5.7% | 0.00% | -50.0% |
Q2 2020 | $1,554,000 | +680.9% | 63,388 | +352.8% | 0.00% | – |
Q1 2020 | $199,000 | -10.4% | 14,000 | 0.0% | 0.00% | – |
Q4 2019 | $222,000 | – | 14,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Corriente Advisors, LLC | 1,915,219 | $23,959,000 | 5.70% |
Prosight Management, LP | 906,569 | $11,341,000 | 5.24% |
P.A.W. CAPITAL CORP | 140,000 | $1,751,000 | 1.54% |
Voss Capital, LLC | 220,714 | $2,761,000 | 1.39% |
Robertson Stephens Wealth Management, LLC | 484,000 | $6,054,000 | 1.26% |
Slate Path Capital LP | 1,483,619 | $18,560,000 | 1.00% |
Nantahala Capital Management | 2,506,772 | $31,360,000 | 0.97% |
PRECEPT MANAGEMENT LLC | 150,000 | $1,877,000 | 0.76% |
SANDERS MORRIS HARRIS LLC | 193,591 | $2,449,000 | 0.56% |
Rock Creek Group, LP | 100,014 | $1,251,000 | 0.51% |